Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +47.56%
#3 Cysic Cysic +41.67%
#4 Glidr Glidr +36.41%
#5 Walrus Walrus +29.37%
#6 Humanity Humanity +23.38%
#7 Codatta Codatta +16.38%
#8 Enso Enso +16.32%
#9 Tutorial Tutorial +15.81%
#10 Ribbita by Virtuals Ribbita by Virtuals +14.43%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
CordovaCann Corp. CordovaCann Corp.

CordovaCann Corp.

CDVA
株式のランク #37110
CordovaCann Corp. is a company that focuses on various aspects of the cannabis... CordovaCann Corp. is a company that focuses on various aspects of the cannabis industry, including identifying prospects, securing financing, developing new ventures, and managing operations throughout the entire cannabis value chain. As of February 14, 2022, it oversaw 14 retail outlets operating under the Star Buds Cannabis Co. brand. These stores are located in the Canadian provinces of Ontario, Manitoba, Alberta, and British Columbia, as well as the U.S. states of Oregon and Washington. The company, whose previous name was LiveReel Media Corporation, officially changed to CordovaCann Corp. in January 2018. Its corporate headquarters are situated in Toronto, Canada.
株価
$0.01834842
最終同期: 2026-07-31
時価総額
$2.01M
変化（1日）
0.00%
変化（1年）
-60.99%
国
CA
取引 CordovaCann Corp. (CDVA)

カテゴリー

Healthcare
CordovaCann Corp.（CDVA）の収益
Aug 2026 時点の収益 TTM: 0
CordovaCann Corp. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
CordovaCann Corp. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN